Extracellular vesicles (EVs) isolated from easily accessible body fluids, such as urine and blood, can be of great diagnostic use. While EVs are attracting considerable interest in the scientific community, it has become evident that analysing them can be methodologically challenging. Recent findings from the EV team at FIMM help to direct the research and expedite standardization of the field.

Ahead of the annual meeting of the Nordic EMBL Partnership for Molecular Medicine, we spoke with its new Speaker, Mark Daly, about the partnership’s goals

The “Behind the Science'' profile series takes an in-depth look at a scientist or group within the Nordic EMBL Partnership. In this article, we meet FIMM’s Academy Research Fellow, Dr. Lassi Paavolainen, and learn about the advances in bioimaging he aims to make as a new group leader at FIMM.

With a broad scope, the new EMBL strategic programme lays out the foundations for the next five years of molecular biology research in the context of its environment. The program includes multidisciplinary collaborations in basic research, research services and training that reach across scales tackling some of the biggest scientific challenges of the times. Learn more on the EMBL website.

DANDRITE Group Leader Taro Kitazawa has been awarded an ERC Starting Grant of EUR 1.5 million from the European Research Council for research into the molecular basis of neuroplasticity to answer the fundamental questions regarding how memory is stored in the brain.

From January 2022, Anna Överby Wernstedt is the new Deputy Director of MIMS, taking over this role from Prof. Maria Fällman.

The “Where Are They Now? Nordic EMBL Partnership Alumni Careers” profile series introduces readers to alumni of the Nordic EMBL Partnership and the careers that they have embarked on. This month we meet Aziz Khan a former postdoc at NCMM and his new career as a staff scientist.

NCMM group leader, Dr. Irep Gözen, and collaborators have been awarded the large, interdisciplinary research project grant from the Research Council of Norway and the University of Oslo

The “Technologies Advancing Molecular Medicine” series highlights the people and activities in research technologies and core facilities in the Nordic EMBL Partnership for Molecular Medicine. In this article, we meet MIMS Team Leader, Linda Sandblad, and learn about the world-class cryo-EM facility she and her team have developed at Umeå University.